Edition:
United Kingdom

Seikagaku Corp (4548.T)

4548.T on Tokyo Stock Exchange

1,831JPY
7:00am BST
Change (% chg)

¥-28 (-1.51%)
Prev Close
¥1,859
Open
¥1,859
Day's High
¥1,859
Day's Low
¥1,827
Volume
80,700
Avg. Vol
189,426
52-wk High
¥2,236
52-wk Low
¥1,535

Select another date:

Fri, Mar 23 2018

BRIEF-Seikagaku announces new drug application approval of hernicore® 1.25 units for intradiscal injection in Japan

* Says it announced that the Japanese Ministry of Health, Labour and Welfare has approved the new drug application of HERNICORE® 1.25 units for intradiscal injection in Japan, indicated for the treatment of lumbar disc herniation

BRIEF-Seikagaku initiates a phase III clinical trial (additional study) in the U.S. for SI-6603

* Says it will initiate a Phase III clinical trial (additional study) in the U.S. for SI-6603, indicated for the treatment of radicular leg pain (i.e. sciatica) due to a lumbar disc herniation.

BRIEF-Ribomic signs collaborative research contract with SEIKAGAKU

* Says it signed collaborative research contract with SEIKAGAKU CORPORATION

Select another date: